Taiwan FDA registration db2c4ef2297cd31122a205cd6cdd5b64
"Anxu Liebo" immunoassay of inhibin-A enzyme
TW: “安旭列博” 抑制素-A酵素免疫分析
Taiwan·Risk Class 2·Ansh Labs LLC·Registered Dec 24, 2014 – Dec 24, 2029ActiveRegistration details
- Analysis ID
- db2c4ef2297cd31122a205cd6cdd5b64
- Customs Code
- DHA05602682902
Company information
- Manufacturer
- Ansh Labs LLC
- Manufacturer Country
- United States
- Authorized Representative
- PROGRESSIVE GROUP INC.
Product details
- Intended Use
- Enzyme immunoassay was used to quantitatively detect the concentration of inhibin A binary in human serum or plasma.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1660 Grade Material (Analysis Material Non-Analysis);; A.1150 Calibrated Products;; A.1260 女二醇試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Dec 24, 2014
- Expiry Date
- Dec 24, 2029
About this record
Access comprehensive regulatory information for "Anxu Liebo" immunoassay of inhibin-A enzyme in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number db2c4ef2297cd31122a205cd6cdd5b64 and manufactured by Ansh Labs LLC. The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices